I 
119TH CONGRESS 
1ST SESSION H. R. 5187 
To establish in the Department of Defense a program to support the 
expansion of domestic bioindustrial manufacturing capacity. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 8, 2025 
Mr. KHANNA (for himself, Mr. GARAMENDI, and Mr. DAVIS of North Caro-
lina) introduced the following bill; which was referred to the Committee 
on Armed Services 
A BILL 
To establish in the Department of Defense a program to 
support the expansion of domestic bioindustrial manufac-
turing capacity. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. BIOINDUSTRIAL COMMERCIALIZATION PRO-
GRAM. 
(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this Act, the Secretary of Defense 
may establish a program to support the expansion of the 
domestic capacity for bioindustrial manufacturing of crit-
ical biomanufactured products at a commercial level 
VerDate Sep 11 2014 
04:48 Sep 10, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5187.IH
H5187
kjohnson on DSK7ZCZBW3PROD with $$_JOB
through awards to eligible entities for establishing, up-
grading, and retooling of eligible bioindustrial manufac-
turing facilities. 
(b) AWARDS.— 
(1) IN GENERAL.—An entity seeking an award 
under the program shall submit to the Secretary an 
application at such time, in such manner, and con-
taining such information as the Secretary deter-
mines appropriate. 
(2) COMPETITIVE
AWARDS.—The Secretary 
shall make each award under the program to an eli-
gible entity in a competitive manner. 
(3) AWARD CRITERIA.—In selecting eligible en-
tities to receive awards under the program, the Sec-
retary shall consider the following criteria: 
(A) The potential of the technology of such 
eligible entity to improve domestic resilience 
and protect critical supply chains for critical 
biomanufactured products. 
(B) How the technology of such eligible en-
tity could help meet the demand for the capa-
bilities required by the next generation of 
warfighters. 
(C) The ability of the eligible bioindustrial 
manufacturing facility with respect to which 
VerDate Sep 11 2014 
04:48 Sep 10, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5187.IH
H5187
kjohnson on DSK7ZCZBW3PROD with $$_JOB
such eligible entity is seeking such award to be 
repurposed and the range of products that such 
eligible bioindustrial manufacturing facility is 
capable of producing. 
(D) Whether the eligible bioindustrial man-
ufacturing facility with respect to which such 
eligible entity is seeking such award supports 
the goal of wide geographic distribution of bio-
industrial manufacturing facility across the 
United States. 
(E) Whether the eligible bioindustrial man-
ufacturing facility with respect to which such 
eligible entity is seeking such award is located 
in geographic proximity to sources of input ma-
terials for the production of critical biomanufac-
tured products or areas with established 
biomanfuacturing capabilities. 
(F) Such additional considerations that the 
Secretary deems appropriate. 
(4) USE OF AWARD FUNDS.—A recipient of an 
award under the program may use funds received 
under such award for the establishment, upgrading, 
or retooling of one or more eligible bioindustrial 
manufacturing facilities to produce critical biomanu-
factured products, including the development of 
VerDate Sep 11 2014 
04:48 Sep 10, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5187.IH
H5187
kjohnson on DSK7ZCZBW3PROD with $$_JOB
business or technical plans related to such establish-
ment, upgrading, or retooling. 
(c) OVERSIGHT.—If the Secretary establishes the 
program, the Secretary shall establish reporting require-
ments for recipients of awards under the program which 
shall include requirements for period reports on the fol-
lowing: 
(1) The progress of the recipient in estab-
lishing, upgrading, or retooling the eligible bioindus-
trial manufacturing facility with respect to which 
such recipient received such award. 
(2) The estimated timeline and funding require-
ments for the recipient to begin biomanufacturing at 
the eligible bioindustrial manufacturing facility de-
scribed in paragraph (1). 
(3) The products, including the critical bio-
manufactured products, that are or will be produced 
at the eligible bioindustrial manufacturing facility 
described in paragraph (1). 
(4) The progress of the recipient in entering 
into an agreement with the Department of Defense 
or an element thereof to provide critical biomanufac-
tured products, that are or will be produced at the 
eligible bioindustrial manufacturing facility described 
VerDate Sep 11 2014 
04:48 Sep 10, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5187.IH
H5187
kjohnson on DSK7ZCZBW3PROD with $$_JOB